Recently, a study from Botto's group suggested that C1q, but not C3, can promote metabolic changes in CD8+ T cells, regulating their function and reducing autoimmunity damage, thereby partially clarifying the discrepancy between C1q and C3 deficiency (87). This evidence concerns the gene C3 and Autoimmunity.